XFOR.OQ - X4 Pharmaceuticals Inc
Guggenheim Securities LLCInitiation
XFOR - BUY - Ph 3 Trial for Mavorixafor in Chronic Neutropenia On Track; Enrollment Completion Reaffirmed for 3Q26
公司
XFOR.OQ
日期
2026-03-17
分析师
Michael Schmidt, PHD
页数
6 页
需要登录
请登录后购买研报或生成音频内容。